Bausch Health Welcomes Two New Members to the Executive Leadership Team

Bausch Health Companies Inc. has announced the appointment of two new members to its Executive Leadership Team. Jean-Jacques Charhon ("JJ") will join the Company as Chief Financial Officer on August 19, 2024. Charhon has over 25 years of experience in financial leadership roles with public and private companies across healthcare, high tech, and services. Upon his arrival, Interim Chief Financial Officer John Barresi will resume his role as SVP, Controller.

Aimee Lenar joined the Company on July 15, 2024, as Executive Vice President, US Pharma. In her new role, she will lead Salix Pharmaceuticals, Bausch Health's gastroenterology business, as well as Neurology, Generics, Market Access, and Commercial Operations. Lenar has over 20 years of experience in the pharmaceutical industry, most recently serving as Head of US Prescription Medicine at Galderma.

CEO Thomas J. Appio expressed delight in welcoming Charhon and Lenar, noting their extensive experience and expertise, which are expected to drive the company's transformation and global integration efforts. Appio also thanked John Barresi for his dedication and efforts as Interim Chief Financial Officer, emphasizing Barresi's integral role in the Financial Leadership Team.